Cytoreductive surgery following neoadjuvant chemotherapy in patients with initial unresectable stage IV ovarian cancer

被引：0
|
作者：
Hogen, Liat [1 ]
Tanen, Adina [2 ]
May, Taymaa [1 ]
Avery, Lisa [3 ]
Ferguson, Sarah [1 ]
Laframboise, Stephane [1 ]
Bouchard-Fortier, Genevieve [1 ]
Bernardini, Marcus [1 ]
机构：
[1] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Temerty Sch Med, Toronto, ON, Canada
[3] Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
来源：
GYNECOLOGIC ONCOLOGY | 2023年 / 176卷
关键词：
D O I：
10.1016/j.ygyno.2023.06.114
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1198
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [21] Clinical Significance of Adjuvant Surgery Following Chemotherapy for Patients with Initially Unresectable Stage IV Gastric Cancer
    Ito, Shuhei
    Oki, Eiji
    Nakashima, Yuichiro
    Ando, Koji
    Hiyoshi, Yukiharu
    Ohgaki, Kippei
    Saeki, Hiroshi
    Morita, Masaru
    Sakaguchi, Yoshihisa
    Maehara, Yoshihiko
    ANTICANCER RESEARCH, 2015, 35 (01) : 401 - 406
  • [22] Prognostic impact of histological response after neoadjuvant chemotherapy in patients with stage IIIC/IV ovarian cancer undergoing complete cytoreductive surgery at the time of interval debulking surgery
    Morice, P.
    Ferron, J.
    Rey, A.
    Zafrani, Y.
    Uzan, C.
    Gouy, S.
    Castaigne, D.
    Duvillard, P.
    L'Homme, C.
    Pautier, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] NEOADJUVANT CHEMOTHERAPY IN THE COMPLEX TREATMENT OF PATIENTS WITH STAGE IIIC - IV OVARIAN CANCER
    Kryzhanivska, Anna
    Djakiv, Iryna
    Hrytsyk, Roman
    ANTICANCER RESEARCH, 2023, 43 (07) : 3377 - 3377
  • [24] Standardization of cytoreductive surgery is a precondition for clinical trials of ovarian cancer including cytoreductive surgery and/or neoadjuvant chemotherapy
    Lim, Myong Cheol
    Park, Sang-Yoon
    GYNECOLOGIC ONCOLOGY, 2012, 125 (02) : 510 - 510
  • [25] Revisiting the role of interval cytoreductive surgery (ICS) following neoadjuvant chemotherapy (NACT) for patients with advanced stage epithelial ovarian cancer; a multicenter database analysis
    Nasioudis, Dimitrios
    Latif, Nawar
    Ko, Emily
    Gysler, Stefan
    Cory, Lori
    Simpkins, Fiona
    Kim, Sarah
    Cliby, William
    Li, Robert Giuntoli
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A199 - A199
  • [26] Randomized pilot study assessing the safety and tolerability hyperthermic intraperitoneal chemotherapy (HIPEC) at completion of interval cytoreductive surgery or chemotherapy the day prior to interval cytoreductive surgery for patients with stage III/IV ovarian cancer undergoing neoadjuvant chemotherapy
    Backes, Floor Jenniskens
    Calo, Corinne
    Chambers, Laura
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Primary cytoreductive surgery or neoadjuvant chemotherapy: A retrospective analysis of 214 patients with stage IIIc and IV ovarian, tubal and peritoneal cancer from the Norwegian Radium Hospital
    Silins, I., Sr.
    Elstrand, M. B.
    Davidson, B.
    Trope, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] Upfront cytoreductive surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer in Indian patients
    Ray, Mukur Dipi
    Deo, Suryanarayana S. V.
    Kumar, Lalit
    Gaur, Manish Kumar
    FUTURE ONCOLOGY, 2021, 17 (27) : 3607 - 3614
  • [29] Impact of neoadjuvant chemotherapy and cytoreductive surgery on patients with advanced ovarian cancer based on bioinformatics analysis
    Luo, L.
    He, W.
    Guo, Q.
    Wang, CY.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2024, 22 (04):
  • [30] Neoadjuvant Chemotherapy Versus Primary Cytoreductive Surgery for Stage IV Uterine Serous Carcinoma
    Wilkinson-Ryan, Ivy
    Frolova, Antonina I.
    Liu, Jingxia
    Massad, L. Stewart
    Thaker, Premal H.
    Powell, Matthew A.
    Mutch, David G.
    Hagemann, Andrea R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (01) : 63 - 68
12345